Search

Samuel Singer has been appointed Chief of the Gastric and Mixed Tumor Service in the Department of Surgery.

… Monday, February 1, 2010 Summary Samuel Singer has been appointed Chief of the Gastric and Mixed Tumor Service in the Department of Surgery. Samuel Singer has been appointed Chief of the Gastric and Mixed Tumor Service in the Department of Surgery. Dr. Singer is a surgical oncologist and leader of Memorial

There are more than 100 subtypes of brain tumors, making them a challenge to accurately diagnose. Now researchers have figured out a way to reliably distinguish them.

… Wednesday, March 14, 2018 Summary Proper diagnosis and classification is vital for brain tumors , but until now it hasn’t been easy. This week an international team of investigators is reporting a new way to distinguish among the 100-plus different subtypes of the disease. There are more than 100 subtypes

A generous gift provides a major boost to translational research at MSK.

… Friday, January 1, 2021 Dear MSK Community, Breakthrough cancer discovery can start anywhere: a patient with a unique case, a researcher with a hunch, or an unexpected result that connects seemingly disparate findings. An investigation into a new treatment can begin with the patient, move to the lab,

Physician-in-Chief Lisa M. DeAngelis joins healthcare experts during the AACR Virtual Meeting: COVID-19 and Cancer to discuss how to safely bring patients to the clinic so they can receive vital cancer screenings and care.

… Friday, July 17, 2020 Thousands of oncology experts from around the world will tune in virtually July 20-22 for the American Association for Cancer Research (AACR) Virtual Meeting: COVID-19 and Cancer . This special AACR conference will focus on emerging data in basic, clinical, and epidemiologic research

Scientists came to give talks and celebrate the achievements that the program has made under the leadership of Kathryn Anderson.

… Wednesday, November 21, 2018 A female scientist speaking Ruth Lehmann, Director of the Skirball Institute of Biomolecular Medicine at NYU Langone Health A male scientist speaking Siegfried Roth, a professor at the Institute for Zoology Biocenter at the University of Cologne, in Germany A female scientist

New data from researchers at Memorial Sloan Kettering Cancer Center (MSK) featured in the 2021 ASCO Annual Meeting press program highlights a promising new treatment option for individuals previously treated for metastatic castration-resistant prostate cancer (mCRPC).

… Thursday, June 3, 2021 New data from researchers at Memorial Sloan Kettering Cancer Center (MSK) featured in the 2021 ASCO Annual Meeting press program highlights a promising new treatment option for individuals previously treated for metastatic castration-resistant prostate cancer (mCRPC). The phase

Learn about the breast cancer type called ductal carcinoma in situ (DCIS) and how doctors decide on the best treatment for each person.

… Tuesday, October 12, 2021 Summary Ductal carcinoma in situ (DCIS) makes up approximately 20% of newly diagnosed breast cancers. But patients are often confused about DCIS, what it means, and what to do about it. We asked MSK surgeon Andrea Barrio to provide some insight into the disease and its treatments

Using patients’ own immune systems to fight cancer has been one of the most exciting advances in cancer treatment over the past decade. Now, a new immunotherapy could take this approach to the next level.

… Thursday, July 1, 2021 Using patients’ own immune systems to fight cancer has been one of the most exciting advances in cancer treatment over the past decade. Now, a new immunotherapy could take this approach to the next level. The treatment, called tumor infiltrating lymphocyte (TIL) therapy, harnesses

The incidence of colorectal cancer in those under the age of 50 has been increasing globally at an alarming rate. Pinpointing the reason remains elusive. Memorial Sloan Kettering has just opened the first center in the world dedicated to research and treatment of the disease as it presents in this demographic.

… Thursday, March 15, 2018 We are excited to announce the opening of the Center for Young Onset Colorectal Cancer at Memorial Sloan Kettering Cancer Center. This is the first center in the world dedicated to adults under the age of 50 with colorectal cancer. Its two-part mission is to: provide coordinated

MSK researchers recently reported results of a phase 2 trial for GIST, a rare form of gastrointestinal cancer. The trial was based on years of lab work conducted by physician-scientist Ping Chi.

… Friday, February 11, 2022 When Luis Portiansky had his first surgery in 1993 for a rare form of cancer that developed in his stomach, Ping Chi was still an undergraduate student at Mount Holyoke College in Massachusetts. More than two decades later, when Luis’ cancer came back for the third time, Dr.